Adebrelimab Combined With SOX Regimen in Preoperative Neoadjuvant Transformation Therapy for Locally Advanced Gastric Adenocarcinoma
Clinical trial NCT06192186 · UNKNOWN
Trial details
- NCT number
- NCT06192186
- Sponsor
- Yang Jianjun, PhD
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-30
- Primary completion
- 2025-12-31
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.